Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,835Open textbooks209Open-access articles1,406Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology182Genetics and Genomics170Neuroscience185Cardiovascular Medicine180Immunology142Pharmacology173Molecular Biology161Infectious Diseases150Rare and Inherited Diseases181Clinical Research173Anatomy and Physiology613Drugs and Chemicals621Psychiatry and Psychology185Public Health and Nutrition178Diagnostics and Medical Technology125Respiratory Medicine113Digestive System and Liver91Metabolism and Endocrine Disease177Bones, Joints, Muscles and Skin213Kidney, Urology and Women's Health173Eye, Ear, Nose and Throat55
Plans & pricingCompare EvidenceHelix workspace plans
Library›Open textbooks›Biomarkers for assessing acute kidney injury for people who are being considered for admission to critical care: a systematic review and cost-effectiveness analysis›References

Continue where you left off ()

Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Biomarkers for assessing acute kidney injury for people who are being considered for admission to critical care: a systematic review and cost-effectiveness analysis · References

References

CC BY 4.0 · NIHR Journals Library · approximately 28 min read

  1. Bedford M, Stevens PE, Wheeler TWK, Farmer CKT. What is the real impact of acute kidney injury? BMC Nephrol 2014;15:95. 10.1186/1471-2369-15-9524952580
  2. Selby NM, Crowley L, Fluck RJ, McIntyre CW, Monaghan J, Lawson N, Kolhe NV. Use of electronic results reporting to diagnose and monitor AKI in hospitalized patients. Clin J Am Soc Nephrol 2012;7:533–40. 10.2215/CJN.0897091122362062
  3. National Confidential Enquiry into Patient Outcome and Death. Adding Insult to Injury: A Review of the Care of Patients Who Died in Hospital with a Primary Diagnosis of Acute Kidney Injury (Acute Renal Failure). A Report by the National Confidential Enquiry into Patient Outcome and Death. London: NCEPOD; 2009.
  4. Bell S, Lim M. Optimizing peri-operative care to prevent acute kidney injury [published online ahead of print September 11 2018]. Nephrol Dial Transplant 2018. 10.1093/ndt/gfy269
  5. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int 2012;2(Supp. 1):1–138.
  6. National institute for Health and Care Excellence. NephroCheck Test to Help Assess the Risk of Acute Kidney Injury in Critically Ill Patients. Medtech Innovation Briefing [MIB156]. 2018. URL: www.nice.org.uk/advice/mib156 (accessed 5 April 2019).
  7. Gocze I, Koch M, Renner P, Zeman F, Graf BM, Dahlke MH, et al. Urinary biomarkers TIMP-2 and IGFBP7 early predict acute kidney injury after major surgery. PLOS ONE 2015;10:e0120863. 10.1371/journal.pone.012086325798585
  8. NHS Digital. Acute Kidney Injury. URL: www.nhs.uk/conditions/acute-kidney-injury/ (accessed 18 April 2019).
  9. O’Connor ME, Kirwan CJ, Pearse RM, Prowle JR. Incidence and associations of acute kidney injury after major abdominal surgery. Intensive Care Med 2016;42:521–30. 10.1007/s00134-015-4157-726602784
  10. Haines RW, Fowler AJ, Kirwan CJ, Prowle JR. The incidence and associations of acute kidney injury in trauma patients admitted to critical care: a systematic review and meta-analysis. J Trauma Acute Care Surg 2019;86:141–7. 10.1097/TA.000000000000208530358765
  11. Bihorac A, Delano MJ, Schold JD, Lopez MC, Nathens AB, Maier RV, et al. Incidence, clinical predictors, genomics, and outcome of acute kidney injury among trauma patients. Ann Surg 2010;252:158–65. 10.1097/SLA.0b013e3181deb6bc20562612
  12. Bihorac A, Brennan M, Ozrazgat-Baslanti T, Bozorgmehri S, Efron PA, Moore FA, et al. National surgical quality improvement program underestimates the risk associated with mild and moderate postoperative acute kidney injury. Crit Care Med 2013;41:2570–83. 10.1097/CCM.0b013e31829860fc23928835
  13. National Institute for Health and Care Excellence. Clinical Knowledge Summary: Acute Kidney Injury. 2018. URL: https://cks.nice.org.uk/acute-kidney-injury (accessed 5 April 2019).
  14. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, Acute Dialysis Quality Initiative workgroup. Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8:R204–12. 10.1186/cc287215312219
  15. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A, Acute Kidney Injury Network. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007;11:R31. 10.1186/cc571317331245
  16. National Institute for Health and Care Excellence. Acute Kidney Injury: Prevention, Detection and Management. Clinical Guideline [CG169]. 2013. URL: www.nice.org.uk/guidance/cg169/chapter/1-Recommendations#assessing-risk-of-acute-kidney-injury (accessed 5 April 2019).
  17. Royal College of Physicians. National Early Warning Score (NEWS)2. 2017. URL: www.rcplondon.ac.uk/projects/outputs/national-early-warning-score-news-2 (accessed 18 April 2019).
  18. NHS England. Acute Kidney Injury (AKI) Algorithm. 2014. URL: www.england.nhs.uk/akiprogramme/aki-algorithm/ (accessed 18 April 2019).
  19. Kidney Disease: Improving Global Outcomes. KDIGO Clinical Practice Guideline for Acute Kidney injury. Online Appendices A–F: March 2012. URL: https://kdigo.org/wp-content/uploads/2016/10/KDIGO-AKI-Suppl-Appendices-A-F_March2012.pdf (accessed 4 April 2019).
  20. Akcan-Arikan A, Zappitelli M, Loftis LL, Washburn KK, Jefferson LS, Goldstein SL. Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int 2007;71:1028–35. 10.1038/sj.ki.500223117396113
  21. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011;155:529–36. 10.7326/0003-4819-155-8-201110180-0000922007046
  22. Wolff RF, Moons KGM, Riley RD, Whiting PF, Westwood M, Collins GS, et al. PROBAST: a tool to assess the risk of bias and applicability of prediction model studies. Ann Intern Med 2019;170:51–8. 10.7326/M18-137630596875
  23. Rutter CM, Gatsonis CA. A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat Med 2001;20:2865–84. 10.1002/sim.94211568945
  24. Harbord RM, Deeks JJ, Egger M, Whiting P, Sterne JA. A unification of models for meta-analysis of diagnostic accuracy studies. Biostatistics 2007;8:239–51. 10.1093/biostatistics/kxl00416698768
  25. Harbord RM, Whiting P. metandi: meta-analysis of diagnostic accuracy using hierarchical logistic regression. Stata J 2009;9:211–29. 10.1177/1536867X0900900203
  26. Cummings JJ, Shaw AD, Shi J, Lopez MG, O’Neal JB, Billings FT. Intraoperative prediction of cardiac surgery-associated acute kidney injury using urinary biomarkers of cell cycle arrest. J Thorac Cardiovasc Surg 2019;157:1545–53.e5. 10.1016/j.jtcvs.2018.08.09030389130
  27. Oezkur M, Magyar A, Thomas P, Stork T, Schneider R, Bening C, et al. TIMP-2*IGFBP7 (Nephrocheck®) measurements at intensive care unit admission after cardiac surgery are predictive for acute kidney injury within 48 hours. Kidney Blood Press Res 2017;42:456–67. 10.1159/00047929828750409
  28. Beitland S, Waldum-Grevbo BE, Nakstad ER, Berg JP, Trøseid AS, Brusletto BS, et al. Urine biomarkers give early prediction of acute kidney injury and outcome after out-of-hospital cardiac arrest. Crit Care 2016;20:314. 10.1186/s13054-016-1503-227716377
  29. Bihorac A, Chawla LS, Shaw AD, Al-Khafaji A, Davison DL, Demuth GE, et al. Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication. Am J Respir Crit Care Med 2014;189:932–9. 10.1164/rccm.201401-0077OC24559465
  30. Di Leo L, Nalesso F, Garzotto F, Xie Y, Yang B, Virzì GM, et al. Predicting acute kidney injury in intensive care unit patients: the role of tissue inhibitor of metalloproteinases-2 and insulin-like growth factor-binding protein-7 biomarkers. Blood Purif 2018;45:270–7. 10.1159/00048559129478052
  31. Xie Y, Ankawi G, Yang B, Garzotto F, Passannante A, Breglia A, et al. Tissue inhibitor metalloproteinase-2 (TIMP-2) • IGF-binding protein-7 (IGFBP7) levels are associated with adverse outcomes in patients in the intensive care unit with acute kidney injury. Kidney Int 2019;95:1486–93. 10.1016/j.kint.2019.01.02030982674
  32. Gayat E, Touchard C, Hollinger A, Vieillard-Baron A, Mebazaa A, Legrand M, FROG ICU study investigators. Back-to-back comparison of penKID with NephroCheck® to predict acute kidney injury at admission in intensive care unit: a brief report. Crit Care 2018;22:24. 10.1186/s13054-018-1945-929378645
  33. Hoste EA, McCullough PA, Kashani K, Chawla LS, Joannidis M, Shaw AD, et al. Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers. Nephrol Dial Transplant 2014;29:2054–61. 10.1093/ndt/gfu29225237065
  34. Kashani K, Al-Khafaji A, Ardiles T, Artigas A, Bagshaw SM, Bell M, et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care 2013;17:R25. 10.1186/cc1250323388612
  35. Kimmel M, Shi J, Wasser C, Biegger D, Alscher MD, Schanz MB. Urinary [TIMP-2] [IGFBP7] – novel biomarkers to predict acute kidney injury. Am J Nephrol 2016;43:375–82. 10.1159/00044645127174659
  36. Kimmel M, Shi J, Latus J, Wasser C, Kitterer D, Braun N, Alscher MD. Association of renal stress/damage and filtration biomarkers with subsequent AKI during hospitalization among patients presenting to the emergency department. Clin J Am Soc Nephrol 2016;11:938–46. 10.2215/CJN.1055101527026519
  37. Parikh CR, Coca SG, Thiessen-Philbrook H, Shlipak MG, Koyner JL, Wang Z, et al. Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery. J Am Soc Nephrol 2011;22:1748–57. 10.1681/ASN.201012130221836143
  38. Parikh CR, Thiessen-Philbrook H, Garg AX, Kadiyala D, Shlipak MG, Koyner JL, et al. Performance of kidney injury molecule-1 and liver fatty acid-binding protein and combined biomarkers of AKI after cardiac surgery. Clin J Am Soc Nephrol 2013;8:1079–88. 10.2215/CJN.1097101223599408
  39. Koyner JL, Coca SG, Thiessen-Philbrook H, Patel UD, Shlipak MG, Garg AX, Parikh CR, Translational Research Investigating Biomarker Endpoints for Acute Kidney Injury (TRIBE-AKI) Consortium. Urine biomarkers and perioperative acute kidney injury: the impact of preoperative estimated GFR. Am J Kidney Dis 2015;66:1006–14. 10.1053/j.ajkd.2015.07.02726386737
  40. Coca SG, Garg AX, Thiessen-Philbrook H, Koyner JL, Patel UD, Krumholz HM, et al. Urinary biomarkers of AKI and mortality 3 years after cardiac surgery. J Am Soc Nephrol 2014;25:1063–71. 10.1681/ASN.201307074224357673
  41. Brown JR, Thiessen-Philbrook H, Goodrich CA, Bohm AR, Alam SS, Coca SG, et al. Are urinary biomarkers better than acute kidney injury duration for predicting readmission? Ann Thorac Surg 2019;107:1699–705. 10.1016/j.athoracsur.2019.02.00530880140
  42. Coca SG, Nadkarni GN, Garg AX, Koyner J, Thiessen-Philbrook H, McArthur E, et al. First Post-operative urinary kidney injury biomarkers and association with the duration of AKI in the TRIBE-AKI cohort. PLOS ONE 2016;11:e0161098. 10.1371/journal.pone.016109827537050
  43. Zhang WR, Garg AX, Coca SG, Devereaux PJ, Eikelboom J, Kavsak P, et al. Plasma IL-6 and IL-10 concentrations predict AKI and long-term mortality in adults after cardiac surgery. J Am Soc Nephrol 2015;26:3123–32. 10.1681/ASN.201408076425855775
  44. Greenberg JH, Devarajan P, Thiessen-Philbrook HR, Krawczeski C, Parikh CR, Zappitelli M, TRIBE-AKI Consortium. Kidney injury biomarkers 5 years after AKI due to pediatric cardiac surgery. Pediatr Nephrol 2018;33:1069–77. 10.1007/s00467-018-3888-429511889
  45. Albert C, Albert A, Bellomo R, Kropf S, Devarajan P, Westphal S, et al. Urinary neutrophil gelatinase-associated lipocalin-guided risk assessment for major adverse kidney events after open-heart surgery. Biomark Med 2018;12:975–85. 10.2217/bmm-2018-007130088425
  46. Garcia-Alvarez M, Glassford NJ, Betbese AJ, Ordoñez J, Baños V, Argilaga M, et al. Urinary neutrophil gelatinase-associated lipocalin as predictor of short- or long-term outcomes in cardiac surgery patients. J Cardiothorac Vasc Anesth 2015;29:1480–8. 10.1053/j.jvca.2015.05.06026296821
  47. Liebetrau C, Dörr O, Baumgarten H, Gaede L, Szardien S, Blumenstein J, et al. Neutrophil gelatinase-associated lipocalin (NGAL) for the early detection of cardiac surgery associated acute kidney injury. Scand J Clin Lab Invest 2013;73:392–9. 10.3109/00365513.2013.78714923668886
  48. Thanakitcharu P, Jirajan B. Determination of urinary neutrophil gelatinase-associated lipocalin (NGAL) cut-off level for early detection of acute kidney injury in Thai adult patients undergoing open cardiac surgery. J Med Assoc Thai 2014;97(Suppl. 11):48–55.
  49. Cullen MR, Jhanji S, Pearse RM, Fitzgibbon MC. Neutrophil gelatinase-associated lipocalin and albuminuria as predictors of acute kidney injury in patients treated with goal-directed haemodynamic therapy after major abdominal surgery. Ann Clin Biochem 2014;51:392–9. 10.1177/000456321350743824123926
  50. Asada T, Isshiki R, Hayase N, Sumida M, Inokuchi R, Noiri E, et al. Impact of clinical context on acute kidney injury biomarker performances: differences between neutrophil gelatinase-associated lipocalin and L-type fatty acid-binding protein. Sci Rep 2016;6:33077. 10.1038/srep3307727605390
  51. Collins SP, Hart KW, Lindsell CJ, Fermann GJ, Weintraub NL, Miller KF, et al. Elevated urinary neutrophil gelatinase-associated lipocalcin after acute heart failure treatment is associated with worsening renal function and adverse events. Eur J Heart Fail 2012;14:1020–9. 10.1093/eurjhf/hfs08722733980
  52. Dupont M, Shrestha K, Singh D, Awad A, Kovach C, Scarcipino M, et al. Lack of significant renal tubular injury despite acute kidney injury in acute decompensated heart failure. Eur J Heart Fail 2012;14:597–604. 10.1093/eurjhf/hfs03922505396
  53. Isshiki R, Asada T, Sumida M, Hamasaki Y, Nangaku M, Noiri E, Doi K. Modest impact of serial measurements of acute kidney injury biomarkers in an adult intensive care unit. Nephron 2018;139:243–53. 10.1159/00048821929614509
  54. Kokkoris S, Parisi M, Ioannidou S, Douka E, Pipili C, Kyprianou T, et al. Combination of renal biomarkers predicts acute kidney injury in critically ill adults. Ren Fail 2012;34:1100–8. 10.3109/0886022X.2012.71327922889061
  55. Mårtensson J, Glassford NJ, Jones S, Eastwood GM, Young H, Peck L, et al. Urinary neutrophil gelatinase-associated lipocalin to hepcidin ratio as a biomarker of acute kidney injury in intensive care unit patients. Minerva Anestesiol 2015;81:1192–200.25479470
  56. Nickolas TL, Schmidt-Ott KM, Canetta P, Forster C, Singer E, Sise M, et al. Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study. J Am Coll Cardiol 2012;59:246–55. 10.1016/j.jacc.2011.10.85422240130
  57. Park M, Hsu CY, Go AS, Feldman HI, Xie D, Zhang X, et al. Urine kidney injury biomarkers and risks of cardiovascular disease events and all-cause death: the CRIC study. Clin J Am Soc Nephrol 2017;12:761–71. 10.2215/CJN.0856081628254771
  58. Pipili C, Ioannidou S, Tripodaki ES, Parisi M, Douka E, Vasileiadis I, et al. Prediction of the renal replacement therapy requirement in mechanically ventilated critically ill patients by combining biomarkers for glomerular filtration and tubular damage. J Crit Care 2014;29:692.e7–13. 10.1016/j.jcrc.2014.02.011
  59. Treeprasertsuk S, Wongkarnjana A, Jaruvongvanich V, Sallapant S, Tiranathanagul K, Komolmit P, Tangkijvanich P. Urine neutrophil gelatinase-associated lipocalin: a diagnostic and prognostic marker for acute kidney injury (AKI) in hospitalized cirrhotic patients with AKI-prone conditions. BMC Gastroenterol 2015;15:140. 10.1186/s12876-015-0372-526474856
  60. Haase M, Bellomo R, Albert C, Vanpoucke G, Thomas G, Laroy W, et al. The identification of three novel biomarkers of major adverse kidney events. Biomark Med 2014;8:1207–17. 10.2217/bmm.14.9025525981
  61. Schley G, Köberle C, Manuilova E, Rutz S, Forster C, Weyand M, et al. Comparison of plasma and urine biomarker performance in acute kidney injury. PLOS ONE 2015;10:e0145042. 10.1371/journal.pone.014504226669323
  62. Jaques DA, Spahr L, Berra G, Poffet V, Lescuyer P, Gerstel E, et al. Biomarkers for acute kidney injury in decompensated cirrhosis: a prospective study. Nephrology 2019;24:170–80. 10.1111/nep.1322629369449
  63. De Loor J, Herck I, Francois K, Van Wesemael A, Nuytinck L, Meyer E, Hoste EAJ. Diagnosis of cardiac surgery-associated acute kidney injury: differential roles of creatinine, chitinase 3-like protein 1 and neutrophil gelatinase-associated lipocalin: a prospective cohort study. Ann Intensive Care 2017;7:24. 10.1186/s13613-017-0251-z28251598
  64. Tidbury N, Browning N, Shaw M, Morgan M, Kemp I, Matata B. Neutrophil gelatinase-associated lipocalin as a marker of postoperative acute kidney injury following cardiac surgery in patients with preoperative kidney impairment. Cardiovasc Hematol Disord Drug Targets 2019;19:239–48. 10.2174/1871529X1966619041511510630987577
  65. Yang X, Chen C, Teng S, Fu X, Zha Y, Liu H, et al. Urinary matrix metalloproteinase-7 predicts severe AKI and poor outcomes after cardiac surgery. J Am Soc Nephrol 2017;28:3373–82. 10.1681/ASN.201702014228698269
  66. Cho E, Kim SC, Kim MG, Jo SK, Cho WY, Kim HK. The incidence and risk factors of acute kidney injury after hepatobiliary surgery: a prospective observational study. BMC Nephrol 2014;15:169. 10.1186/1471-2369-15-16925342079
  67. Ariza X, Graupera I, Coll M, Solà E, Barreto R, García E, et al. Neutrophil gelatinase-associated lipocalin is a biomarker of acute-on-chronic liver failure and prognosis in cirrhosis. J Hepatol 2016;65:57–65. 10.1016/j.jhep.2016.03.00226988732
  68. Barreto R, Elia C, Solà E, Moreira R, Ariza X, Rodríguez E, et al. Urinary neutrophil gelatinase-associated lipocalin predicts kidney outcome and death in patients with cirrhosis and bacterial infections. J Hepatol 2014;61:35–42. 10.1016/j.jhep.2014.02.02324613364
  69. Cho E, Yang HN, Jo SK, Cho WY, Kim HK. The role of urinary liver-type fatty acid-binding protein in critically ill patients. J Korean Med Sci 2013;28:100–5. 10.3346/jkms.2013.28.1.10023341719
  70. Doi K, Noiri E, Nangaku M, Yahagi N, Jayakumar C, Ramesh G. Repulsive guidance cue semaphorin 3A in urine predicts the progression of acute kidney injury in adult patients from a mixed intensive care unit. Nephrol Dial Transplant 2014;29:73–80. 10.1093/ndt/gft41424166457
  71. Doi K, Negishi K, Ishizu T, Katagiri D, Fujita T, Matsubara T, et al. Evaluation of new acute kidney injury biomarkers in a mixed intensive care unit. Crit Care Med 2011;39:2464–9. 10.1097/CCM.0b013e318225761a21705884
  72. Hjortrup PB, Haase N, Treschow F, Møller MH, Perner A. Predictive value of NGAL for use of renal replacement therapy in patients with severe sepsis. Acta Anaesthesiol Scand 2015;59:25–34. 10.1111/aas.1242725363361
  73. Matsa R, Ashley E, Sharma V, Walden AP, Keating L. Plasma and urine neutrophil gelatinase-associated lipocalin in the diagnosis of new onset acute kidney injury in critically ill patients. Crit Care 2014;18:R137. 10.1186/cc1395824985156
  74. Nickolas TL, O’Rourke MJ, Yang J, Sise ME, Canetta PA, Barasch N, et al. Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med 2008;148:810–19. 10.7326/0003-4819-148-11-200806030-0000318519927
  75. Nisula S, Yang R, Poukkanen M, Vaara ST, Kaukonen KM, Tallgren M, et al. Predictive value of urine interleukin-18 in the evolution and outcome of acute kidney injury in critically ill adult patients. Br J Anaesth 2015;114:460–8. 10.1093/bja/aeu38225472925
  76. Nisula S, Yang R, Kaukonen KM, Vaara ST, Kuitunen A, Tenhunen J, et al. The urine protein NGAL predicts renal replacement therapy, but not acute kidney injury or 90-day mortality in critically ill adult patients. Anesth Analg 2014;119:95–102. 10.1213/ANE.000000000000024324806144
  77. Smith ER, Lee D, Cai MM, Tomlinson LA, Ford ML, McMahon LP, Holt SG. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric stages 3 and 4 chronic kidney disease (CKD). Nephrol Dial Transplant 2013;28:1569–79. 10.1093/ndt/gfs58623328709
  78. Tecson KM, Erhardtsen E, Eriksen PM, Gaber AO, Germain M, Golestaneh L, et al. Optimal cut points of plasma and urine neutrophil gelatinase-associated lipocalin for the prediction of acute kidney injury among critically ill adults: retrospective determination and clinical validation of a prospective multicentre study. BMJ Open 2017;7:e016028. 10.1136/bmjopen-2017-016028
  79. Verna EC, Brown RS, Farrand E, Pichardo EM, Forster CS, Sola-Del Valle DA, et al. Urinary neutrophil gelatinase-associated lipocalin predicts mortality and identifies acute kidney injury in cirrhosis. Dig Dis Sci 2012;57:2362–70. 10.1007/s10620-012-2180-x22562534
  80. Zelt JGE, Mielniczuk LM, Liu PP, Dupuis JY, Chih S, Akbari A, Sun LY. Utility of novel cardiorenal biomarkers in the prediction and early detection of congestive kidney injury following cardiac surgery. J Clin Med 2018;7:E540. 10.3390/jcm712054030545066
  81. Itenov TS, Jensen JU, Ostrowski SR, Johansson PI, Thormar KM, Lundgren JD, Bestle MH, ‘Procalcitonin And Survival Study’ study group. Endothelial damage signals refractory acute kidney injury in critically ill patients. Shock 2017;47:696–701. 10.1097/SHK.000000000000080428505627
  82. Lee DH, Lee BK, Cho YS, Jung YH, Lee SM, Park JS, Jeung KW. Plasma neutrophil gelatinase-associated lipocalin measured immediately after restoration of spontaneous circulation predicts acute kidney injury in cardiac arrest survivors who underwent therapeutic hypothermia. Ther Hypothermia Temp Manag 2018;8:99–107. 10.1089/ther.2017.003929131707
  83. Marino R, Struck J, Hartmann O, Maisel AS, Rehfeldt M, Magrini L, et al. Diagnostic and short-term prognostic utility of plasma pro-enkephalin (pro-ENK) for acute kidney injury in patients admitted with sepsis in the emergency department. J Nephrol 2015;28:717–24. 10.1007/s40620-014-0163-z25486879
  84. Parikh CR, Devarajan P, Zappitelli M, Sint K, Thiessen-Philbrook H, Li S, et al. Postoperative biomarkers predict acute kidney injury and poor outcomes after pediatric cardiac surgery. J Am Soc Nephrol 2011;22:1737–47. 10.1681/ASN.201011116321836147
  85. Zappitelli M, Greenberg JH, Coca SG, Krawczeski CD, Li S, Thiessen-Philbrook HR, et al. Association of definition of acute kidney injury by cystatin C rise with biomarkers and clinical outcomes in children undergoing cardiac surgery. JAMA Pediatr 2015;169:583–91. 10.1001/jamapediatrics.2015.5425844892
  86. Bojan M, Vicca S, Lopez-Lopez V, Mogenet A, Pouard P, Falissard B, Journois D. Predictive performance of urine neutrophil gelatinase-associated lipocalin for dialysis requirement and death following cardiac surgery in neonates and infants. Clin J Am Soc Nephrol 2014;9:285–94. 10.2215/CJN.0473051324262504
  87. Bennett M, Dent CL, Ma Q, Dastrala S, Grenier F, Workman R, et al. Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clin J Am Soc Nephrol 2008;3:665–73. 10.2215/CJN.0401090718337554
  88. Cantinotti M, Storti S, Lorenzoni V, Arcieri L, Moschetti R, Murzi B, et al. The combined use of neutrophil gelatinase-associated lipocalin and brain natriuretic peptide improves risk stratification in pediatric cardiac surgery. Clin Chem Lab Med 2012;50:2009–17. 10.1515/cclm-2012-012523089537
  89. Alcaraz AJ, Gil-Ruiz MA, Castillo A, López J, Romero C, Fernández SN, Carrillo A. Postoperative neutrophil gelatinase-associated lipocalin predicts acute kidney injury after pediatric cardiac surgery. Pediatr Crit Care Med 2014;15:121–30. 10.1097/PCC.000000000000003424366512
  90. Seitz S, Rauh M, Gloeckler M, Cesnjevar R, Dittrich S, Koch AM. Cystatin C and neutrophil gelatinase-associated lipocalin: biomarkers for acute kidney injury after congenital heart surgery. Swiss Med Wkly 2013;143:w13744. 10.4414/smw.2013.1374423348800
  91. Zwiers AJ, de Wildt SN, van Rosmalen J, de Rijke YB, Buijs EA, Tibboel D, Cransberg K. Urinary neutrophil gelatinase-associated lipocalin identifies critically ill young children with acute kidney injury following intensive care admission: a prospective cohort study. Crit Care 2015;19:181. 10.1186/s13054-015-0910-025895828
  92. Dong L, Ma Q, Bennett M, Devarajan P. Urinary biomarkers of cell cycle arrest are delayed predictors of acute kidney injury after pediatric cardiopulmonary bypass. Pediatr Nephrol 2017;32:2351–60. 10.1007/s00467-017-3748-728755073
  93. Lagos-Arevalo P, Palijan A, Vertullo L, Devarajan P, Bennett MR, Sabbiesetti V, et al. Cystatin C in acute kidney injury diagnosis: early biomarker or alternative to serum creatinine? Pediatr Nephrol 2015;30:665–76. 10.1007/s00467-014-2987-025475610
  94. Park JT. Postoperative acute kidney injury. Korean J Anesthesiol 2017;70:258–66. 10.4097/kjae.2017.70.3.25828580076
  95. Parikh A, Rizzo JA, Canetta P, Forster C, Sise M, Maarouf O, et al. Does NGAL reduce costs? A cost analysis of urine NGAL (uNGAL) & serum creatinine (sCr) for acute kidney injury (AKI) diagnosis. PLOS ONE 2017;12:e0178091. 10.1371/journal.pone.017809128542336
  96. National Institute for Health and Care Excellence. Guide to the Methods of Technology Appraisal 2013. Process and Methods [PMG9]. URL: www.nice.org.uk/process/pmg9/ (accessed 24 October 2019).
  97. Hall PS, Mitchell ED, Smith AF, Cairns DA, Messenger M, Hutchinson M, et al. The future for diagnostic tests of acute kidney injury in critical care: evidence synthesis, care pathway analysis and research prioritisation. Health Technol Assess 2018;22(32). 10.3310/hta22320
  98. Petrovic S, Bogavac-Stanojevic N, Lakic D, Peco-Antic A, Vulicevic I, Ivanisevic I, et al. Cost-effectiveness analysis of acute kidney injury biomarkers in pediatric cardiac surgery. Biochem Med 2015;25:262–71. 10.11613/BM.2015.027
  99. Shaw AD, Chalfin DB, Kleintjens J. The economic impact and cost-effectiveness of urinary neutrophil gelatinase-associated lipocalin after cardiac surgery. Clin Ther 2011;33:1713–25. 10.1016/j.clinthera.2011.09.01422071237
  100. National Institute for Health and Care Excellence Diagnostics Assessment Programme. The ARCHITECT and Alinity i Urine NGAL Assay, NephroCheck Test and NGAL Test to Help Assess the Risk of Acute Kidney Injury for People who are Being Considered for Admission to Critical Care: Final Scope. London: NICE; 2019.
  101. National Institute for Health and Care Excellence. Diagnostics Assessment Programme Manual. 2011. URL: www.nice.org.uk/Media/Default/About/what-we-do/NICE-guidance/NICE-diagnostics-guidance/Diagnostics-assessment-programme-manual.pdf (accessed 5 April 2019).
  102. Sawhney S, Marks A, Fluck N, Levin A, Prescott G, Black C. Intermediate and long-term outcomes of survivors of acute kidney injury episodes: a large population-based cohort study. Am J Kidney Dis 2017;69:18–28. 10.1053/j.ajkd.2016.05.01827555107
  103. Sawhney S, Mitchell M, Marks A, Fluck N, Black C. Long-term prognosis after acute kidney injury (AKI): what is the role of baseline kidney function and recovery? A systematic review. BMJ Open 2015;5:e006497. 10.1136/bmjopen-2014-006497
  104. Jacobsen E, Sawhney S, Brazzelli M, Aucott L, Scotland G, Aceves-Martins M, et al. Cost-effectiveness and value of information analysis of NephroCheck and NGAL tests compared to standard care for the diagnosis of acute kidney injury. BMC Nephrol 2021;22:399. 10.1186/s12882-021-02610-934852765
  105. National Institute for Health and Care Excellence. Chronic Kidney Disease in Adults: Assessment and Management. Clinical Guideline [CG182]. 2014. URL: www.nice.org.uk/guidance/cg182 (accessed 2 May 2019).
  106. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005;67:2089–100. 10.1111/j.1523-1755.2005.00365.x15882252
  107. Sawhney S, Robinson HA, van der Veer SN, Hounkpatin HO, Scale TM, Chess JA, et al. Acute kidney injury in the UK: a replication cohort study of the variation across three regional populations. BMJ Open 2018;8:e019435. 10.1136/bmjopen-2017-019435
  108. Truche AS, Ragey SP, Souweine B, Bailly S, Zafrani L, Bouadma L, et al. ICU survival and need of renal replacement therapy with respect to AKI duration in critically ill patients. Ann Intensive Care 2018;8:127. 10.1186/s13613-018-0467-630560526
  109. Bastin AJ, Ostermann M, Slack AJ, Diller GP, Finney SJ, Evans TW. Acute kidney injury after cardiac surgery according to Risk/Injury/Failure/Loss/End-stage, Acute Kidney Injury Network, and Kidney Disease: Improving Global Outcomes classifications. J Crit Care 2013;28:389–96. 10.1016/j.jcrc.2012.12.00823743540
  110. Meersch M, Schmidt C, Hoffmeier A, Van Aken H, Wempe C, Gerss J, Zarbock A. Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial. Intensive Care Med 2017;43:1551–61. 10.1007/s00134-016-4670-328110412
  111. Rimes-Stigare C, Frumento P, Bottai M, Mårtensson J, Martling CR, Walther SM, et al. Evolution of chronic renal impairment and long-term mortality after de novo acute kidney injury in the critically ill; a Swedish multi-centre cohort study. Crit Care 2015;19:221. 10.1186/s13054-015-0920-y25944032
  112. See EJ, Jayasinghe K, Glassford N, Bailey M, Johnson DW, Polkinghorne KR, et al. Long-term risk of adverse outcomes after acute kidney injury: a systematic review and meta-analysis of cohort studies using consensus definitions of exposure. Kidney Int 2019;95:160–72. 10.1016/j.kint.2018.08.03630473140
  113. Kent S, Schlackow I, Lozano-Kühne J, Reith C, Emberson J, Haynes R, Gray A, et al. What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease? BMC Nephrol 2015;16(65). 10.1186/s12882-015-0054-0
  114. Lone NI, Gillies MA, Haddow C, Dobbie R, Rowan KM, Wild SH, et al. Five-year mortality and hospital costs associated with surviving intensive care. Am J Respir Crit Care Med 2016;194:198–208. 10.1164/rccm.201511-2234OC26815887
  115. UK Renal Registry. UK Renal Registry 21st Annual Report: Data to 31/12/2017. 2019. URL: www.renalreg.org/publications-reports/ (accessed 24 October 2019).
  116. Göcze I, Jauch D, Götz M, Kennedy P, Jung B, Zeman F, et al. Biomarker-guided intervention to prevent acute kidney injury after major surgery. Ann Surg 2018;267:1013–20. 10.1097/SLA.000000000000248528857811
  117. Schanz M, Wasser C, Allgaeuer S, Schricker S, Dioppon J, Alscher MD, et al. Urinary [TIMP-2].[IGFBP7]-guided randomized controlled intervention trial to prevent acute kidney injury in the emergency department. Nephrol Dial Transplant 2019;34:1902–9. 10.1093/ndt/gfy18629961888
  118. Wilson FP, Shashaty M, Testani J, Aqeel I, Borovskiy Y, Ellenberg SS, et al. Automated, electronic alerts for acute kidney injury: a single-blind, parallel-group, randomised controlled trial. Lancet 2015;385:1966–74. 10.1016/S0140-6736(15)60266-525726515
  119. Kerr M. 2012. Chronic Kidney Disease in England: The Human and Financial Cost. URL: www.england.nhs.uk/improvement-hub/wp-content/uploads/sites/44/2017/11/Chronic-Kidney-Disease-in-England-The-Human-and-Financial-Cost.pdf (accessed 24 October).
  120. Heung M, Steffick DE, Zivin K, Gillespie BW, Banerjee T, Hsu CY, et al. Acute kidney injury recovery pattern and subsequent risk of CKD: an analysis of Veterans Health administration data. Am J Kidney Dis 2016;67:742–52. 10.1053/j.ajkd.2015.10.01926690912
  121. Wu B, Ma L, Shao Y, Liu S, Yu X, Zhu Y, et al. Effect of cardiac surgery-associated acute kidney injury on long-term outcomes of Chinese patients: a historical cohort study. Blood Purif 2017;44:227–33. 10.1159/00047896728873378
  122. Shimoi T, Ando M, Munakata W, Kobayashi T, Kakihana K, Ohashi K, et al. The significant impact of acute kidney injury on CKD in patients who survived over 10 years after myeloablative allogeneic SCT. Bone Marrow Transplant 2013;48:80–4. 10.1038/bmt.2012.8522635246
  123. Office for National Statistics. National Life Tables: UK. 2019. URL: www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/lifeexpectancies/datasets/nationallifetablesunitedkingdomreferencetables (accessed 31 October 2019).
  124. Personal Social Services Research Unit. Unit Costs of Health and Social Care 2018. Canterbury: University of Kent. URL: www.pssru.ac.uk/project-pages/unit-costs/ (accessed 9 September 2019).
  125. NHS Improvement. Reference Costs. 2017. URL: https://improvement.nhs.uk/resources/reference-costs/ (accessed 9 September 2019).
  126. Joint Formulary Committee. British National Formulary (online). London: BMJ Group and Pharmaceutical Press. URL: www.medicinescomplete.com (accessed 25 October 2019).
  127. Campbell and Cochrane Economics Methods Group. 2019. CCEMG – EPPI-Centre Cost Converter. URL: https://eppi.ioe.ac.uk/costconversion/ (accessed 24 October 2019).
  128. National Institute for Health and Care Excellence. Kidney Transplantation (Adults) – Immunosuppressive Therapy (Review of TA 85) [ID456]. 2015. URL: www.nice.org.uk/guidance/GID-TAG348/documents/html-content. (accessed November 2016).
  129. Palevsky PM, Zhang JH, O’Connor TZ, Chertow GM, Crowley ST, Choudhury D, et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008;359:7–20. 10.1056/NEJMoa080263918492867
  130. Bagshaw SM, Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, et al. Timing of renal replacement therapy and clinical outcomes in critically ill patients with severe acute kidney injury. J Crit Care 2009;24:129–40. 10.1016/j.jcrc.2007.12.01719272549
  131. Scotland G, Cruickshank M, Jacobsen E, Cooper D, Fraser C, Shimonovich M, et al. Multiple-frequency bioimpedance devices for fluid management in people with chronic kidney disease receiving dialysis: a systematic review and economic evaluation. Health Technol Assess 2018;22(1). 10.3310/hta22010
  132. Kind P, Hardman G, Macran S. UK Population Norms for EQ-5D. Centre for Health Economics discussion paper 172. York: Centre for Health Economics, University of York; 1999.
  133. Hernández RA, Jenkinson D, Vale L, Cuthbertson BH. Economic evaluation of nurse-led intensive care follow-up programmes compared with standard care: the PRaCTICaL trial. Eur J Health Econ 2014;15:243–52. 10.1007/s10198-013-0470-723535984
  134. Wyld M, Morton RL, Hayen A, Howard K, Webster AC. A systematic review and meta-analysis of utility-based quality of life in chronic kidney disease treatments. PLOS Med 2012;9:e1001307. 10.1371/journal.pmed.100130722984353
  135. Cuthbertson BH, Roughton S, Jenkinson D, Maclennan G, Vale L. Quality of life in the five years after intensive care: a cohort study. Crit Care 2010;14:R6. 10.1186/cc884820089197
  136. Nguyen NTQ, Cockwell P, Maxwell AP, Griffin M, O’Brien T, O’Neill C. Chronic kidney disease, health-related quality of life and their associated economic burden among a nationally representative sample of community dwelling adults in England. PLOS ONE 2018;13:e0207960. 10.1371/journal.pone.020796030475893
  137. Liem YS, Bosch JL, Hunink MG. Preference-based quality of life of patients on renal replacement therapy: a systematic review and meta-analysis. Value Health 2008;11:733–41. 10.1111/j.1524-4733.2007.00308.x18194399
  138. Ara R, Brazier JE. Populating an economic model with health state utility values: moving toward better practice. Value Health 2010;13:509–18. 10.1111/j.1524-4733.2010.00700.x20230546
  139. Dritsaki M, Achana F, Mason J, Petrou S. Methodological issues surrounding the use of baseline health-related quality of life data to inform trial-based economic evaluations of interventions within emergency and critical care settings: a systematic literature review. PharmacoEconomics 2017;35:501–15. 10.1007/s40273-016-0485-x28063084
  140. Gerth AMJ, Hatch RA, Young JD, Watkinson PJ. Changes in health-related quality of life after discharge from an intensive care unit: a systematic review. Anaesthesia 2019;74:100–8. 10.1111/anae.14444
  141. Ara R, Brazier JE. Using health state utility values from the general population to approximate baselines in decision analytic models when condition-specific data are not available. Value Health 2011;14:539–45. 10.1016/j.jval.2010.10.02921669378
  142. Tappenden P, Chilcott JB. Avoiding and identifying errors and other threats to the credibility of health economic models. PharmacoEconomics 2014;32:967–79. 10.1007/s40273-014-0186-225027943
  143. Sawhney S, Fluck N, Marks A, Prescott G, Simpson W, Tomlinson L, Black C. Acute kidney injury – how does automated detection perform? Nephrol Dial Transplant 2015;30:1853–61. 10.1093/ndt/gfv09425925702
  144. Tomašev N, Glorot X, Rae JW, Zielinski M, Askham H, Saraiva A, et al. A clinically applicable approach to continuous prediction of future acute kidney injury. Nature 2019;572:116–19. 10.1038/s41586-019-1390-131367026
  145. Janes H, Pepe MS, McShane LM, Sargent DJ, Heagerty PJ. The fundamental difficulty with evaluating the accuracy of biomarkers for guiding treatment. J Natl Cancer Inst 2015;107:djv157. 10.1093/jnci/djv15726109106
  146. Zarbock A, Kellum JA, Schmidt C, Van Aken H, Wempe C, Pavenstädt H, et al. Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the ELAIN randomized clinical trial. JAMA 2016;315:2190–9. 10.1001/jama.2016.582827209269
  147. Gaudry S, Hajage D, Schortgen F, Martin-Lefevre L, Pons B, Boulet E, et al. Initiation strategies for renal-replacement therapy in the intensive care unit. N Engl J Med 2016;375:122–33. 10.1056/NEJMoa160301727181456
  148. Murray PT, Mehta RL, Shaw A, Ronco C, Endre Z, Kellum JA, et al. Potential use of biomarkers in acute kidney injury: report and summary of recommendations from the 10th Acute Dialysis Quality Initiative consensus conference. Kidney Int 2014;85:513–21. 10.1038/ki.2013.37424107851
  149. Rifkin DE, Coca SG, Kalantar-Zadeh K. Does AKI truly lead to CKD? J Am Soc Nephrol 2012;23:979–84. 10.1681/ASN.201112118522460531
  150. Hsu CY. Yes, AKI truly leads to CKD. J Am Soc Nephrol 2012;23:967–9. 10.1681/ASN.201203022222499588
  151. Afiatin KLC, Kristin E, Masytoh LS, Herlinawaty E, Werayingyong P, Nadjib M, et al. Economic evaluation of policy options for dialysis in end-stage renal disease patients under the universal health coverage in Indonesia. PLOS ONE 2017;12. 10.1371/journal.pone.0177436
  152. Chang YT, Hwang JS, Hung SY, Tsai MS, Wu JL, Sung JM, Wang JD. Cost-effectiveness of hemodialysis and peritoneal dialysis: a national cohort study with 14 years follow-up and matched for comorbidities and propensity score. Sci Rep 2016;6:30266. 10.1038/srep3026627461186
  153. Cho MK, Kim SY, Shim HY. Validity and reliability of the Korean version of the Dialysis Symptom Index for Hemodialysis Patients. J Nurs Res 2018;26:399–410. 10.1097/jnr.000000000000026729994803
  154. Eriksson D, Goldsmith D, Teitsson S, Jackson J, van Nooten F. Cross-sectional survey in CKD patients across Europe describing the association between quality of life and anaemia. BMC Nephrol 2016;17:97. 10.1186/s12882-016-0312-927460779
  155. El Filali A, Bentata Y, Ada N, Oneib B. Depression and anxiety disorders in chronic hemodialysis patients and their quality of life: a cross-sectional study about 106 cases in the northeast of Morocco. Saudi J Kidney Dis Transpl 2017;28:341–8. 10.4103/1319-2442.20278528352018
  156. Hishii S, Miyatake N, Nishi H, Katayama A, Ujike K, Koumoto K, et al. Relationship between sedentary behavior and health-related quality of life in patients on chronic hemodialysis. Acta Med Okayama 2018;72:395–400. 10.18926/AMO/5617730140088
  157. Jardine MJ, Zuo L, Gray NA, de Zoysa JR, Chan CT, Gallagher MP, et al. A trial of extending hemodialysis hours and quality of life. J Am Soc Nephrol 2017;28:1898–911. 10.1681/ASN.201511122528151412
  158. Jesky MD, Dutton M, Dasgupta I, Yadav P, Ng KP, Fenton A, et al. Health-related quality of life impacts mortality but not progression to end-stage renal disease in pre-dialysis chronic kidney disease: a prospective observational study. PLOS ONE 2016;11:e0165675. 10.1371/journal.pone.016567527832126
  159. National Institute for Health and Care Excellence. Chronic Kidney Disease: Early Identification and Management of Chronic Kidney Disease in Adults in Primary and Secondary Care. Clinical Guideline [CG73]. 2008. URL: http://nice.org.uk/CG73 (accessed 5 April 2019).
  160. Katayama A, Miyatake N, Nishi H, Ujike K, Hashimoto H, Kurato R, et al. Relationship between changes in physical activity and changes in health-related quality of life in patients on chronic hemodialysis with 1-year follow-up. Acta Med Okayama 2016;70:353–61. 10.18926/AMO/5459327777427
  161. Kilshaw L, Sammut H, Asher R, Williams P, Saxena R, Howse M. A study to describe the health trajectory of patients with advanced renal disease who choose not to receive dialysis. Clin Kid J 2016;9:470–5. 10.1093/ckj/sfw005
  162. Kularatna S, Senanayake S, Gunawardena N, Graves N. Comparison of the EQ-5D 3L and the SF-6D (SF-36) contemporaneous utility scores in patients with chronic kidney disease in Sri Lanka: a cross-sectional survey. BMJ Open 2019;9:e024854. 10.1136/bmjopen-2018-024854
  163. Lee SJ, Son H. Comparison of health-related quality of life between patients with stage 3 and 4 chronic kidney disease and patients undergoing continuous ambulatory peritoneal dialysis. Jpn J Nurs Sci 2016;13:166–73. 10.1111/jjns.1210126542889
  164. Li B, Cairns JA, Draper H, Dudley C, Forsythe JL, Johnson RJ, et al. Estimating health-state utility values in kidney transplant recipients and waiting-list patients using the EQ-5D-5L. Value Health 2017;20:976–84. 10.1016/j.jval.2017.01.01128712628
  165. McNoe B, Schollum JBW, Derrett S, Marshall MP, Henderson A, Samaranayaka A, et al. Recruitment and participant baseline characteristics in the dialysis outcomes in those aged 65 years or older study. BMC Nephrol 2019;20:137. 10.1186/s12882-019-1328-831014261
  166. Nagasawa H, Sugita I, Tachi T, Esaki H, Yoshida A, Kanematsu Y, et al. The relationship between dialysis patients’ quality of life and caregivers’ quality of life. Front Pharmacol 2018;16:770. 10.3389/fphar.2018.00770
  167. Schlackow I, Kent S, Herrington W, Emberson J, Haynes R, Reith C, et al. A policy model of cardiovascular disease in moderate-to-advanced chronic kidney disease. Heart 2017;103:1880–90. 10.1136/heartjnl-2016-31097028780579
  168. Sekercioglu N, Curtis B, Murphy S, Blackhouse G, Barret G. Estimates of health utility scores in chronic kidney disease. Int Urol Nephrol 2017;49:2043–9. 10.1007/s11255-017-1664-128733768
  169. Senanayake S, Mahesh PKB, Gunawardena N, Graves N, Sanjeewa Kularatna. Validity and internal consistency of EQ-5D-3L quality of life tool among pre-dialysis patients with chronic kidney disease in Sri Lanka, a lower middle-income country. PLOS ONE 2019;14:e0211604. 10.1371/journal.pone.021160431242189
  170. Shah KK, Murtagh FEM, McGeechan K, Crail S, Burns A, Tran AD, Morton RL. Health-related quality of life and well-being in people over 75 years of age with end-stage kidney disease managed with dialysis or comprehensive conservative care: a cross-sectional study in the UK and Australia. BMJ Open 2019;9:e027776. 10.1136/bmjopen-2018-027776
  171. Shimizu U, Aoki H, Sakagami M, Akazawa K. Walking ability, anxiety and depression, significantly decrease EuroQol 5-Dimension 5-Level scores in older hemodialysis patients in Japan. Arch Gerontol Geriatr 2018;78:96–100. 10.1016/j.archger.2018.06.00629936330
  172. Snowsill TM, Moore J, Mujica Mota RE, Peters JL, Jones-Hughes TL, Huxley NJ, et al. Immunosuppressive agents in adult kidney transplantation in the National Health Service: a model-based economic evaluation. Nephrol Dial Transplant 2017;32:1251–9. 10.1093/ndt/gfx07428873970
  173. Tang CH, Wu YT, Huang SY, Chen HH, Wu MJ, Hsu BG. Economic costs of automated and continuous ambulatory peritoneal dialysis in Taiwan: a combined survey and retrospective cohort analysis. BMJ Open 2017;7:e015067. 10.1136/bmjopen-2016-015067
  174. Thaweethamcharoen T, Noparatayaporn P, Sritippayawan S, Aiyasanon N. Comparison of EQ-5D-5L, VAS, and SF-6D in Thai patients on peritoneal dialysis. Value Health Reg Issues 2019;18:59–64. 10.1016/j.vhri.2018.08.00530502661
  175. Van Loon IN, Bots ML, Boereboom FTJ, Grooteman MPC, Blankestijn PJ, van den Dorpet MA, et al. Quality of life as indicator of poor outcome in hemodialysis: relation with mortality in different age groups. BMC Nephrology 2017;18:217. 10.1186/s12882-017-0621-728679361
  176. Wee HL, Seng BJ, Lee JJ, Chong KJ, Yyagi P, Vathsala A, et al. Association of anemia and mineral and bone disorder with health-related quality of life in Asian pre-dialysis patients. Health Qual Life Outcomes 2016;14:94. 10.1186/s12955-016-0477-827342630
  177. Wolfgram DF, Garcia K, Evans G, Zamanian S, Tang R, Wiegmann T, et al. Association of albuminuria and estimated glomerular filtration rate with functional performance measures in older adults with chronic kidney disease. Am J Nephrol 2017;45:172–9. 10.1159/00045538828118620
  178. Wong CKH, Chen JY, Fung SKS, Lo WK, Lui SL, Chan TM, et al. Health-related quality of life and health utility of Chinese patients undergoing nocturnal home haemodialysis in comparison with other modes of dialysis. Nephrology (Carlton) 2019;24:630–7. 10.1111/nep.1342929926521
  179. Yang F, Wong CKH, Luo N, Piercy J, Moon R, Jackson J. Mapping the kidney disease quality of life 36-item short form survey (KDQOL-36) to the EQ-5D-3L and the EQ-5D-5L in patients undergoing dialysis. Eur J Health Econ 2019;20:1195–206. 10.1007/s10198-019-01088-531338698
  180. Yang F, Luo N, Lau T, Yu ZL, Foo MWY, Griva K. Health-related quality of life in patients treated with continuous ambulatory peritoneal dialysis and automated peritoneal dialysis in Singapore. Pharmacoecon Open 2018;2:203–8. 10.1007/s41669-017-0046-z29623617
  181. Zyoud SH, Daraghmeh DN, Mezyed DO, Khdeir RL, Sawafta MN, Ayaseh NH, et al. Factors affecting quality of life in patients on haemodialysis: a cross-sectional study from Palestine. BMC Nephrology 2016;17:44. 10.1186/s12882-016-0257-z27117687
  182. Park JI, Baek H, Jung HH. CKD and health-related quality of life: the Korea National Health and Nutrition Examination Survey. Am J Kidney Dis 2016;67:851–60. 10.1053/j.ajkd.2015.11.00526706255
  183. Tan BK, Yu Z, Fang W, Lin A, Ni Z, Qian J. Longitudinal bioimpedance vector plots add little value to fluid management of peritoneal dialysis patients. Kidney Int 2016;89:487–97. 10.1038/ki.2015.29426466321
  184. Ethgen O, Schneider AG, Bagshaw SM, Bellomo R, Kellum JA. Economics of dialysis dependence following renal replacement therapy for critically ill acute kidney injury patients. Nephrol Dial Transplant 2015;30:54–61. 10.1093/ndt/gfu31425326472
  185. Kaier K, Gutmann A, Baumbach H, von Zur Mühlen C, Hehn P, Vach W, et al. Quality of life among elderly patients undergoing transcatheter or surgical aortic valve replacement – a model-based longitudinal data analysis. Health Qual Life Outcomes 2016;14:109. 10.1186/s12955-016-0512-927456092
  186. Oeyen S, De Corte W, Benoit D, Annemans L, Dhondt A, Vanholder R, et al. Long-term quality of life in critically ill patients with acute kidney injury treated with renal replacement therapy: a matched cohort study. Crit Care 2015;19:289. 10.1186/s13054-015-1004-826250830
  187. Soliman IW, Frencken JF, Peelen LM, Slooter AJ, Cremer OL, van Delden JJ, et al. The predictive value of early acute kidney injury for long-term survival and quality of life of critically ill patients. Crit Care 2016;20:242. 10.1186/s13054-016-1416-027488839
← ConclusionsAcknowledgements →

Attribution. Miriam Brazzelli; Lorna Aucott; Magaly Aceves-Martins; Clare Robertson; Elisabet Jacobsen; Mari Imamura et al. (2022). Biomarkers for assessing acute kidney injury for people who are being considered for admission to critical care: a systematic review and cost-effectiveness analysis. NIHR Journals Library. Copyright © Queen’s Printer and Controller of HMSO 2022. This work was produced by Brazzelli et al. under the terms of a commissioning contract issued by the Secretary of State for Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK. Licensed under CC BY 4.0. NCBI Bookshelf NBK577538. CC BY 4.0. Original source ↗. Text reproduced from the Bookshelf XML without changing wording; figures, images and supplements are not reproduced.

In this chapter Contents

  • References

Source

OpenStax source file ↗

Source record ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Rights and removal requests · Legal · Support